Sesen Bio Inc (SESN)

[the gipper]

SESN PR looks excellent. It sure looks like fall is lining up to be very positive. Mid 2019 results for Vista/Vicinium trial If they continue to be as thus far could initiate a bidding war from BP. The fact that Vicinium is believed to combine well with immunity-oncology drugs could be huge. Exciting days ahead for SESN!
The fact that SESN currently has 46 Million cash reserves to fund activities into 2020 places them in a very strong position for negotiations which seem likely in 2019, and could be sooner. AIMHO